BTAI BioXcel Therapeutics, Inc. Common Stock

XNAS 1.88 Delayed
Find condors

Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Fibonacci levels Insider trading

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.

BTAI $1.88 —
Key stats
$1.88
52-Week Range
$0.07 – $2.33
YTD
+10.53%
Straddle Price
$1.85
P/C Vol Ratio
0.17
Market Cap
$0.0B
Open
$0.09
Day Range
$0.07 – $0.09
Volume
47,432,390
Prev Close
$0.12
Fair Value
+50.0% vs price

A blended fair-value estimate combining up to six valuation methods. Each method is weighted by how well it fits the company — DCF down-weights for unprofitable names; DDM only fires for steady dividend payers; comparables down-weight when peer multiples disagree.

  • DCF (quality-aware) — projects free cash flow with a horizon that scales to business quality. True compounders (quality 6/6) get 10 years explicit + 10 years fade before terminal; cyclical/struggling names (quality 0-1) get a 5-year terminal cliff. Quality is scored from ROE, gross margin, growth, FCF margin, debt load, and FCF consistency — the same factors that drive market premium for compounders.
  • Market-Implied Growth (in Model Inputs) — reverse-DCF that answers "what growth rate is the market pricing in?". Lets you sanity-check the deviation: if implied growth is plausible for the business, the model's bearish flag may be wrong; if implausible, the market may be over-extrapolating.
  • DDM (Gordon Growth Dividend Model) — values the stream of future dividends. Only used when trailing yield ≥ 2% and dividend payments are stable — below that the dividend is a token payout and Gordon (which values only the dividend stream) systematically underprices growth names, so those route to DCF + comparables + market anchor instead.
  • P/E, EV/EBITDA, P/B, P/S — applies the peer-group median multiple to this company's per-share metric. Peers come from the same set as the "Related symbols" card. Earnings/sales metrics are forward-tilted by the company's recent revenue growth (capped at 25%) so they're comparable to peers' growth-embedded multiples — mimics how analysts use NTM rather than TTM. Per-multiple weights are biased by company quality (e.g. P/B down-weighted for asset-light tech).
  • Market Anchor (SMA50) — the 50-day moving average, weighted by recent trading-range stability (tighter Bollinger bands → higher weight). Captures information fundamentals miss (forward consensus, sentiment, supply/demand) — but only when recent trading is steady enough that the market has converged on a view. During wild breakouts or breakdowns the anchor's weight collapses.
  • Options Expected (B-L 30d) — the risk-neutral expected stock price at 30-day options expiration, derived from the full implied-volatility surface via Breeden-Litzenberger (second derivative of call price wrt strike → implied PDF, then E[S_T]). Forward-looking, captures all options-implied information (smile, skew, term structure) in one number. Weighted by chain liquidity. SP500-only at present (pre-computed daily). Backtest evidence: adds modest alpha across most bucket × holding combos.
  • Blended value — weighted average. Confidence reflects how many methods fired and how tight peer dispersion is.
  • Deviation pill — green when blended FV ≥ 10% above current price (undervalued); red when ≥ 10% below; grey otherwise.
10-yr Treasury (rf)4.78%
Beta vs SPY1.44
Cost of Equity (CAPM)11.64% (VRP-adj)
WACC10.07%
Volatility Risk Premium-434.9pp (IV − HV30), ERP adj -25bps
Effective Tax Rate21.0%
Rev. Growth (YoY, DCF input)+30.0%
DCF Horizon10 years explicit + fade
Forward Tilt (NTM/TTM)×1.10 (applied to P/E, EV/EBITDA, P/S)
Free Cash Flow (TTM)$-0.1B
Return on Equity (TTM)61.4%
Book / Price-6941.9%
Gross Margin (TTM)53.1%
FCF Margin (TTM)-6860.4%
Quality Score3/6 — normal (10y DCF)
SMA 50$0.84 (Market Anchor value)
SMA 20 / Bollinger Mid$0.66
Bollinger Width / SMA2033919.1% (drives anchor stability)
Net Debt$-0.0B
Market Cap$0B
Blended Fair Value
$0.84
Deviation
+50.0%
MethodImplied PriceWeightDetail
DCF n/a 0%
DDM (Gordon) n/a 0%
Peer P/E n/a 0%
Peer EV/EBITDA n/a 0%
Peer P/B n/a 0%
Peer P/S n/a 0%
Market Anchor (SMA50) $0.84 100% stability 69% (BB-width)
Options Expected (B-L 30d) n/a 0%
As of 2026-09-09 · updated
About
Industry (SIC)
PHARMACEUTICAL PREPARATIONS (2834) · industry map
Exchange
XNAS
Market Cap
$0.0B
Employees
29
List Date
2018-03-08
CIK
0001720893
Headquarters
New Haven, CT
Homepage
https://www.bioxceltherapeutics.com

BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology. The pipeline products of the company are-BXCL501, being evaluated as a potential treatment for agitation associated with multiple neurological disorders and BXCL701, an investigational oral innate immune activator for the treatment of aggressive forms of prostate cancer and other solid and liquid tumors. The company's commercial product, IGALMI (developed as…

Summary
—
composite
—
No summary data available for this symbol yet.

Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.

Chart
Seasonality
'21'22'23'24'25'26Avg
Jan-11.35%-25.97%32.90%9.90%-16.84%-6.47%-2.97%
Feb3.65%8.41%8.28%0.00%-56.13%5.70%-5.02%
Mar-22.53%14.32%-41.36%-12.15%-45.87%-17.79%-20.90%
Apr-9.73%-39.16%7.96%-10.64%-3.65%0.82%-9.07%
May0.49%-16.13%-13.79%-28.74%-33.52%-2.50%-15.70%
Jun-15.28%22.11%-63.31%-24.26%37.12%18.49%-4.19%
Jul-10.56%8.20%15.99%-4.27%-33.50%-41.02%-10.86%
Aug13.49%-0.73%-49.60%-40.29%195.62%-80.79%6.28%
Sep0.70%-15.87%-33.94%-1.60%-32.63%-46.06%-21.57%
Oct-5.11%9.10%65.23%18.75%-20.23%--13.55%
Nov-26.86%35.82%-13.44%-36.45%18.42%--*-4.50%
Dec-0.49%19.53%-24.16%-13.07%-22.33%---8.10%
Total-61.38%-8.50%-87.93%-82.82%-83.15%-94.21%-69.67%
Technical Indicators

Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.

Trend Indicators
  • SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
  • EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
  • MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
  • ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
  • +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
  • RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
  • Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
  • Williams %R — inverted scale: <−80 oversold, >−20 overbought.

Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.

Volume & Volatility
  • Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
  • OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
  • Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
  • ATR / True Range — average daily $ move; sizing and stop-loss reference.
  • HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.

Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →

Trend Indicators

SMA 20: $0.66
SMA 50: $0.84
SMA 200: $1.34
Current: $0.07
EMA 12: $0.38
EMA 26: $0.60
MACD: -0.2196 | Signal: -0.0736
BEARISH
ADX (14): 26.81
TREND
+DI: 14.59
−DI: 45.23

Momentum Oscillators

RSI (14): 20.14
OVERSOLD
Stoch %K: 0.67
Stoch %D: 0.95
Williams %R: -99.41

Volume & Volatility

BB Upper: $1.39
BB Lower: $-0.07
NEUTRAL
OBV: 554,180,237
Vol SMA 20: 17,382,534
Vol ROC: 3726.53%
ATR: $0.10
True Range: $0.05
HV 20: 521.1%
HV 30: 434.9%
HV 60: 323.3%

Data Summary

Data Points: 500
Last Updated:
Date Range: 2024-09-09T00:00:00 – 2026-09-04T00:00:00
AI Analysis

Click Frenzy-Pro™ for an AI analysis of this ticker.

Analysis includes technical indicators, news sentiment, risk assessment, and specific price levels to watch.

News
All BTAI news →
Showing 1–10 of 50
Page 1 of 5
Earnings History
14 of 21 under expected move
Avg Expected Move
47.61%
Avg Actual Move
10.59%
Each row pairs the pre-earnings straddle-implied expected move with the realized close-to-close move. Sorted oldest first.
Earnings Date Timing Expected Move Actual Move Ratio Outcome
2021-01-14 Pre-Market 5.69% 6.37% 1.12x Exceeded
2021-05-10 Pre-Market 1.03% 0.39% 0.38x Within
2021-08-10 Pre-Market 2.65% 0.24% 0.09x Within
2021-11-10 Pre-Market 0.65% 1.21% 1.86x Exceeded
2022-01-13 Pre-Market 3.06% 1.92% 0.63x Within
2022-03-10 Pre-Market 12.39% 4.13% 0.33x Within
2022-05-09 Pre-Market 1.43% 9.55% 6.68x Exceeded
2022-08-09 Pre-Market 0.76% 7.58% 9.97x Exceeded
2022-11-10 Pre-Market 2.28% 29.27% 12.84x Exceeded
2023-03-09 Pre-Market 0.73% 13.40% 18.36x Exceeded
2023-05-08 Pre-Market 14.59% 13.64% 0.93x Within
2023-08-14 Pre-Market 20.27% 41.49% 2.05x Exceeded
2023-11-14 Pre-Market 36.13% 23.41% 0.65x Within
2024-03-12 Pre-Market 16.67% 4.48% 0.27x Within
2024-05-09 Pre-Market 11.11% 8.73% 0.79x Within
2024-07-16 Pre-Market 315.57% 9.84% 0.03x Within
2024-11-14 Pre-Market 75.00% 15.93% 0.21x Within
2025-03-27 Pre-Market 102.56% 5.96% 0.06x Within
2025-05-12 Pre-Market 120.92% 3.27% 0.03x Within
2025-08-12 Pre-Market 168.42% 6.25% 0.04x Within
2025-11-12 Pre-Market 87.87% 15.35% 0.17x Within

Earnings calendar: this week’s reports with expected vs actual moves →

BTAI Options Activity & IV Rank

Volatility Metrics

Current IV: —
7-DTE IV: —
Expected Move: $1.85
7-DTE Move: $1.85
Days to Exp: — (2026-01-16)

Options Flow

Call Volume: 307
Put Volume: 53
P/C Volume: 0.173
BULLISH
Call OI: 8,543
Put OI: 440
P/C OI: 0.052
Total OI: 8,983

ATM Options Pricing

ATM Call: $0.03
ATM Put: $1.82
Call %: 1.3%
Put %: 97.1%

Chain Summary

Chain Volume: 360
Chain OI: 8,983
Last Updated: 1/16/2026
Spread Scanner GPU
Full Algorithm Docs ↗

Each spread is ranked by a composite score built in three stages. Full documentation →

Stage 1 — Base Score (GPU scanner)

score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.

Stage 2 — Skew Adjustment (±25% cap)

RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.

Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
  • RSI <40 bullish / >60 bearish
  • MACD crossover + histogram trend
  • Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
  • Stochastic %K <20 / >80
  • Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
  • Blended ATR + straddle expected-move penalty
  • Bollinger Band signal (+ counter-trend penalty)
  • BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
  • IV rank ≥ 75 → strong boost for credit spreads
  • IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
  • Min open interest across all legs
  • OI < 100 → −0.10 · OI < 500 → −0.05

score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →

Enter a ticker to scan for optimal spread opportunities.

Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.

Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Metric:
Wing vs ATM
IV(put wing) − IV(ATM), in vol points

How much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.

  • Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
  • Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
  • Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
  • Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each side

Which side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.

  • Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
  • Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
  • Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
  • Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Reading them together

Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:

  • High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
  • Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
  • Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d —
— pts EXTREME
as of Jan 14 · No data
30 DTE / 10d —
— pts EXTREME
as of Jan 14 · No data

Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.

Volatility Surface

Enter a ticker to render the implied volatility surface.

Volatility Smile

Enter a ticker to render the implied volatility smile.

IV Rank (7 DTE)
IV Rank (30 DTE)
Straddle Price (30 DTE)$1.85Jan 16
Beta Analysis

Risk Metrics

Beta: 2.4720
Alpha: -292.08%
Correlation: 0.2411
R-Squared: 5.8%
Stock Volatility: 134.5%
Market Volatility: 13.1%

Analysis Details

Benchmark: SPY
Data Points: 209
Period: 252 trading days
Interpretation:
High volatility - stock moves more than market
Beta & Alpha Over Time
Notable investors who own BTAI
3 of 37 tracked investors
InvestorValueShare of their portfolioRankQ/Q sharesSource
Millennium Management Hedge fund
Izzy Englander
$3.0M
0.00%
#2359 of 3716+9.2%13F
Oaktree Capital Asset manager
Howard Marks
$1.9M
0.04%
#114 of 130+472.3%13F
Citadel Hedge fund
Ken Griffin
$210K
0.00%
#5436 of 6285new13F

Hedge funds, activists, holding companies and family offices we track, from their latest 13F (quarter-end value) and Form 4 filings in the last 3 years. Family offices · all institutions

BTAI Institutional Ownership (13F)

Latest filings — 2026-09-30
Diluted shares outstanding: 22,506,500 (as of 2026-06-30)

Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.

  • Shares — long equity positions in this name, aggregated across share classes.
  • Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
  • % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
  • Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.

Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.

43 filers6,438,504 shares$9.13M value28.61% of float
# Filer Shares Value % of Total % of Float Period
1 Millennium Management LLC Custodian 2,114,710 $2.98M 32.66% 9.40% 2026-06-30
2 OAKTREE CAPITAL MANAGEMENT LP 1,380,248 $1.95M 21.32% 6.13% 2026-06-30
3 Vanguard Capital Management LLC 919,545 $1.30M 14.20% 4.09% 2026-06-30
4 Vanguard Group Inc Custodian 292,753 $468.40K 5.13% 1.30% 2025-12-31
5 Oaktree Fund Advisors, LLC 245,585 $346.27K 3.79% 1.09% 2026-06-30
6 Geode Capital Management, LLC Custodian 242,251 $341.91K 3.75% 1.08% 2026-06-30
7 BlackRock, Inc. Custodian 179,433 $253.00K 2.77% 0.80% 2026-06-30
8 UBS Group AG Custodian 158,065 $222.87K 2.44% 0.70% 2026-06-30
9 Citadel Advisors LLC Custodian 149,220 $210.40K 2.30% 0.66% 2026-06-30
10 Vanguard Fiduciary Trust Co 136,937 $193.08K 2.12% 0.61% 2026-06-30
11 State Street Corp 92,118 $129.89K 1.42% 0.41% 2026-06-30
12 FMR LLC Custodian 90,300 $127.32K 1.39% 0.40% 2026-06-30
13 &PARTNERS 83,588 $117.86K 1.29% 0.37% 2026-06-30
14 Jones Financial Companies LLLP Custodian 63,139 $82.71K 0.91% 0.28% 2026-06-30
15 Northern Trust Corp Custodian 56,318 $79.41K 0.87% 0.25% 2026-06-30
16 HighTower Advisors, LLC 41,000 $57.81K 0.63% 0.18% 2026-06-30
17 Quadrature Capital Ltd 38,038 $53.63K 0.59% 0.17% 2026-06-30
18 Headlands Technologies LLC 25,556 $36.03K 0.39% 0.11% 2026-06-30
19 StoneX Group Inc. 20,684 $29.16K 0.32% 0.09% 2026-06-30
20 Beacon Pointe Advisors, LLC 18,837 $26.56K 0.29% 0.08% 2026-06-30
21 Susquehanna International Group, LLP Custodian 17,200 $24.25K 0.27% 0.08% 2026-06-30
22 Portfolio Strategies, Inc. 16,831 $23.73K 0.26% 0.07% 2026-06-30
23 Virtu Financial LLC 15,967 $23.00K 0.25% 0.07% 2026-06-30
24 OSAIC HOLDINGS, INC. Custodian 16,214 $22.86K 0.25% 0.07% 2026-06-30
25 TWO SIGMA SECURITIES, LLC 10,796 $15.22K 0.17% 0.05% 2026-06-30
# Filer Notional Value % of Total Period
# Filer Notional Value % of Total Period

BTAI Insider Trading (Form 4)

Latest: 2026-08-14
Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
Filed Reporter Role Action Shares Avg Price Net $ Link
2026-08-14 Susan E. Atkins Director Grant (A) +17,000 opt — EDGAR
2026-06-17 Javier Rodriguez See Remarks Exer (M) +35 — EDGAR
2026-06-17 Richard I Steinhart Chief Financial Officer Exer (M) +35 — EDGAR
2026-06-17 Vimal Mehta CEO and President Exer (M) +219 — EDGAR
2026-06-17 Frank Yocca Chief Scientific Officer Exer (M) +35 — EDGAR
2026-05-22 Frank Yocca Chief Scientific Officer Mixed +10,655 $1.08 -$7.4K EDGAR
2026-05-22 Vimal Mehta CEO and President Mixed +30,339 $1.09 -$21.1K EDGAR
2026-05-22 Javier Rodriguez See Remarks Mixed +10,940 $1.08 -$7.1K EDGAR
2026-05-22 Richard I Steinhart Chief Financial Officer Mixed +10,655 $1.08 -$7.4K EDGAR
2026-05-07 Vimal Mehta CEO and President Exer (M) +18,000 — EDGAR
2026-05-07 Javier Rodriguez See Remarks Exer (M) +9,000 — EDGAR
2026-05-07 Frank Yocca Chief Scientific Officer Exer (M) +9,000 — EDGAR
2026-05-07 Richard I Steinhart Chief Financial Officer Exer (M) +9,000 — EDGAR
2026-03-16 Richard I Steinhart Chief Financial Officer Exer (M) +68 — EDGAR
2026-03-16 Javier Rodriguez See Remarks Exer (M) +68 — EDGAR
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.

BTAI Insider Holdings

8 insiders · @ $0.07
Officers, directors, and 10%+ owners who have filed a Form 4 in the past two years, ranked by current disclosed exposure (shares × today's price). Shares are direct + indirect (via trusts / LLCs / spouse). Excludes unvested RSU and option grants — those aren't beneficially owned until vest.
# Insider Role Shares Disclosed Exposure Lifetime OM Net Filings Last Filed
1 Vimal Mehta CEO and President 550,160 $40.7K -$18.36M 40 2026-06-17
2 Javier Rodriguez See Remarks 26,838 $2.0K -$81.8K 26 2026-06-17
3 Richard I Steinhart Chief Financial Officer 26,335 $1.9K -$364.6K 32 2026-06-17
4 Frank Yocca Chief Scientific Officer 26,210 $1.9K -$3.79M 35 2026-06-17
5 David J. Mack Director 20,317 $1.5K $0 15 2026-01-12
6 Peter Mueller Director 13,112 $969 $152.9K 13 2026-01-12
7 Matthew T. Wiley Chief Commercial Officer 1,580 $117 -$6.6K 8 2025-04-01
8 Vincent O'Neill See Remarks 1,247 $92 -$4.82M 19 2025-04-01
Lifetime OM Net = signed sum of open-market buys (P) and sells (S) over their career; excludes grants, tax withholdings, and dispositions to issuer. A large negative number is normal for long-tenured executives — they've sold compensation grants over many years.

BTAI Board & Officers

As of SEC filings through Aug 14, 2026

Directors 8

Officers 4

  • Vimal Mehta · CEO and President · listed since Feb 2022
  • Javier Rodriguez · Chief Legal Officer, Senior Vice President and Corporate Secretary · listed since Mar 2023
  • Richard I Steinhart · Chief Financial Officer · since Mar 7, 2018
  • Frank Yocca · Chief Scientific Officer · since Mar 7, 2018
Changes in the last 10 years (52)
Aug 12, 2026Susan E. Atkins became a director
Apr 1, 2025Vincent O'Neill reported in an SEC filing no longer being Executive Vice President, Chief of Product Development and Medical Officer
Apr 1, 2025Matthew T. Wiley reported in an SEC filing no longer being Chief Commercial Officer
Mar 17, 2025Vimal Mehta no longer listed as a 10% owner in SEC filings
Jan 15, 2025Rajiv Patni became a director
Nov 21, 2024David J. Mack became a director
Jun 6, 2024Vimal Mehta first listed as a 10% owner in an SEC filing
Apr 8, 2024Vincent O'Neill listed as Executive Vice President, Chief of Product Development and Medical Officer (previously Chief Medical Officer) in SEC filings
Sep 19, 2023The company announced the departure of Sandeep Laumas from the board in an SEC filing
Sep 19, 2023The company announced the departure of Krishnan Nandabalan from the board in an SEC filing
Apr 3, 2023Vipin Agarwal became a 10% owner
Apr 3, 2023Tarun K. Gupta became a 10% owner
Apr 3, 2023Suganthi Balasubramanian became a 10% owner
Apr 3, 2023Rashmi Agarwal became a 10% owner
Apr 3, 2023Pardeep Kumar Sood became a 10% owner
Apr 3, 2023Michael James Aiello became a 10% owner
Apr 3, 2023Marshal D. Gibson became a 10% owner
Apr 3, 2023Krunal Dilip Patel became a 10% owner
Apr 3, 2023Jatin Markand Patel became a 10% owner
Apr 3, 2023Indu R. Gupta became a 10% owner
Not reported recently (21)
  • BioXcel LLC · Last reported as a 10% owner in an SEC filing dated Jun 6, 2024
  • BioXcel Holdings, Inc. · Last reported as a 10% owner in an SEC filing dated Jun 6, 2024
  • Michael James Aiello · Last reported as a 10% owner in an SEC filing dated Apr 26, 2023
  • Suganthi Balasubramanian · Last reported as a 10% owner in an SEC filing dated Apr 14, 2023
  • Rashmi Agarwal · Last reported as a 10% owner in an SEC filing dated Apr 13, 2023
  • Anesha Agarwal · Last reported as a 10% owner in an SEC filing dated Apr 13, 2023
  • Jatin Markand Patel · Last reported as a 10% owner in an SEC filing dated Apr 13, 2023
  • Alka Sood · Last reported as a 10% owner in an SEC filing dated Apr 13, 2023
  • Krunal Dilip Patel · Last reported as a 10% owner in an SEC filing dated Apr 13, 2023
  • Pardeep Kumar Sood · Last reported as a 10% owner in an SEC filing dated Apr 13, 2023
  • Bina Jatin Patel · Last reported as a 10% owner in an SEC filing dated Apr 13, 2023
  • Anita Jain · Last reported as a 10% owner in an SEC filing dated Apr 13, 2023
  • Marshal D. Gibson · Last reported as a 10% owner in an SEC filing dated Apr 13, 2023
  • Akrati Agarwal · Last reported as a 10% owner in an SEC filing dated Apr 13, 2023
  • Indu R. Gupta · Last reported as a 10% owner in an SEC filing dated Apr 13, 2023
  • Vipin Agarwal · Last reported as a 10% owner in an SEC filing dated Apr 13, 2023
  • Tarun K. Gupta · Last reported as a 10% owner in an SEC filing dated Apr 13, 2023
  • Diwakar Jain · Last reported as a 10% owner in an SEC filing dated Apr 13, 2023
  • Krishnan Nandabalan · Last reported as a 10% owner in an SEC filing dated Apr 10, 2023
  • William P Kane Jr · Last reported as Chief Commercial Officer in an SEC filing dated Aug 18, 2021
  • Reina Benabou · Last reported as an officer in an SEC filing dated Jun 23, 2020
Compiled from SEC filings by the company and its directors and officers. Dates are as stated in those filings. Where no filing says when someone left, we show the last filing that listed them.

BTAI Proposed Insider Sales (Form 144)

Latest: 2026-05-20
Last 30d: 0 filings  ·  Last 90d: 0 filings

What is Form 144? A notice of intent to sell restricted or control stock under Rule 144. Affiliates (officers, directors, 10%+ owners) and holders of restricted shares must file Form 144 when planning to sell more than 5,000 shares or $50,000 in any 3-month rolling window.

How it relates to Form 4: Form 144 is filed before the trade (up to 90 days in advance); Form 4 is filed within 2 business days after the trade executes. Not every Form 144 results in a sale — the filer may cancel or delay. Look for the corresponding Form 4 on the Insider Activity card to confirm a sale actually happened.

10b5-1 plans: Trades made under a pre-scheduled Rule 10b5-1 plan are not discretionary — they execute automatically on dates set months earlier, regardless of news. High 10b5-1 percentages mean less per-filing signal value, though cumulative selling volume still matters.

"Notice value": Aggregate market value the filer wrote into the Form 144 — i.e. the size of the planned sale, not necessarily the executed dollars. An amended notice (Form 144/A) replaces the original it amends, and cancelled notices are dropped, so neither is double-counted above. A filed value that is clearly inconsistent with the share count at the stock's price (a filer typo) shows as a dash and is left out of the totals.

Source & freshness: Sourced from public Form 144 filings. Refreshed daily; new filings typically appear here the morning after they are filed.

Filed Filer Role Shares Notice Value Planned Sale Broker Plan Link
2026-05-20 Mehta Vimal Officer 19,419 $21.1K 2026-05-20 Merrill Lynch 10b5-1 EDGAR
2026-05-20 Rodriguez Javier Officer 6,560 $7.1K 2026-05-20 Merrill Lynch 10b5-1 EDGAR
2026-05-20 Yocca Frank Officer 6,845 $7.4K 2026-05-20 Merrill Lynch 10b5-1 EDGAR
2026-05-20 Steinhart Richard I Officer 6,845 $7.4K 2026-05-20 Merrill Lynch 10b5-1 EDGAR
2024-12-16 O'Neill Vincent Officer 165 $58 2024-12-16 Merrill Lynch 10b5-1 EDGAR
2024-12-16 Rodriguez Javier Officer 430 $153 2024-12-16 Merrill Lynch 10b5-1 EDGAR
2024-12-16 144/A Steinhart Richard I Officer 430 $154 2024-12-16 Merrill Lynch 10b5-1 EDGAR
2024-12-16 Yocca Frank Officer 430 $152 2024-12-16 Merrill Lynch 10b5-1 EDGAR
2024-12-16 Mehta Vimal Officer 983 $340 2024-12-16 Merrill Private Wealth Managemen… 10b5-1 EDGAR
2024-10-03 Rodriguez Javier Officer 6,863 $3.8K 2024-10-03 Merrill Lynch 10b5-1 EDGAR
Notice value is the aggregate market value the filer states they intend to sell — not a confirmed transaction. Compare to Insider Activity (Form 4) to see which planned sales actually executed. Market-wide feed: Planned sales (Form 144).
ETF Holders
# ETF Provider Weight $ Exposure ETF AUM As Of
Fundamentals

Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.

Metrics
  • Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
  • Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
  • Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
  • Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
  • Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
  • YoY growth — compare to the same quarter a year earlier to remove seasonality.
  • Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
  • Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.

TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.

Trailing P/E
—
TTM Diluted EPS
$-3.78
TTM Revenue
$742.00K
TTM Net Income
$-70.86M
TTM Op. Cash Flow
$-50.90M
Quarterly figures (12 quarters)
QuarterPeriod EndRevenueNet IncomeDiluted EPSOp. Cash Flow
Q2 '262026-06-30$182.00K$-14.71M$-0.49$-6.10M
Q1 '262026-03-31$206.00K$-12.69M$-0.54$-11.81M
Q4 '252025-12-31$256.00K$-12.54M$0.65$-14.21M
Q3 '252025-09-30$98.00K$-30.91M$-2.18$-18.79M
Q2 '252025-06-30$120.00K$-19.19M$-2.45$-12.57M
Q1 '252025-03-31$168.00K$-7.25M$-1.50$-12.04M
Q4 '242024-12-31$366.00K$-10.86M$-2.91$-14.81M
Q3 '242024-09-30$214.00K$-13.65M$-5.15$-16.34M
Q2 '242024-06-30$1.10M$-8.30M$-3.30$-23.17M
Q1 '242024-03-31$582.00K$-26.79M$-13.89$-17.71M
Q4 '232023-12-31$376.00K$-22.26M$-11.93$-26.86M
Q3 '232023-09-30$341.00K$-50.49M$-27.52$-37.58M
Q2 2026 • period ending 2026-06-30 • filed 2026-08-13
Valuation

Ratios derived from TTM financials and the current market price, sampled daily. History chart shows how expensive the stock is today relative to its own recent past.

Price Multiples
  • P/E — price / TTM earnings. Rough market rule: 10–15 value, 15–25 market, >30 growth/premium. Negative when earnings are negative.
  • P/B — price / book value. Useful for financials and asset-heavy names; meaningless for asset-light software.
  • P/S — price / TTM revenue. Useful when earnings are negative or noisy (early-stage growth).
  • EV/EBITDA — capital-structure-neutral. <10 cheap, 10–15 reasonable, >20 rich. Good for comparing across leverage profiles.
  • EV/Sales — like P/S but accounts for debt + cash. Compare within sector.
Profitability & Yields
  • ROE — return on equity. >15% strong, >25% exceptional. Caution: high leverage inflates ROE.
  • ROA — return on assets. Leverage-neutral; >5% solid, >10% exceptional.
  • Div Yield — annual dividend / price. Compare to 10Y Treasury; sustained yield >6% often signals distress.
  • FCF Yield — free cash flow / market cap. >5% is attractive; negative means burning cash.
Balance Sheet
  • Debt/Equity — leverage. <1 conservative, >2 aggressive. Sector-dependent (utilities naturally high, tech low).
  • Current Ratio — short-term liquidity. >1.5 comfortable, <1 raises short-term solvency flags.
Reading the history chart
  • Compare current level to the 3-year band: near the high end = relatively expensive; near the low = relatively cheap.
  • Multiples expanding while earnings are flat = sentiment-driven rally.
  • Multiples compressing while earnings grow = value coming from fundamentals.
P/E
—
P/B
—
P/S
2.24
EV/EBITDA
—
EV/Sales
-15.06
ROE
—
ROA
-246.1%
Div Yield
0.00%
FCF Yield
-3060.55%
Debt/Equity
—
Current Ratio
—
Market Cap
$1.66M
as of 2026-09-04
Short Interest & Float

Regulatory short-interest reports publish on a bi-weekly settlement cadence; short-volume is reported daily by the trade-reporting facilities. Float is derived from insider-ownership filings.

Metric definitions
  • Short Interest — total shares currently sold short as of the settlement date. Lags real time by ~8 business days.
  • SI % of Float — short interest / free float. The key crowding metric.
  • Days to Cover — short interest / avg daily volume. How many full trading days it would take shorts to buy back. High DTC + catalyst = squeeze fuel.
  • Short Vol Ratio — today's short-sale volume / total volume. Intraday selling pressure proxy (not the same as short interest).
  • Free Float — shares available for public trading (total shares minus insider / restricted).
  • Float % — free float / shares outstanding. <50% = tightly held, more prone to squeezes.
How to read the signals
  • SI % of Float < 5% — typical, no particular signal.
  • 5–15% — elevated; watch for catalysts (earnings, guidance, macro).
  • 15–30% — heavily shorted; tight-float names in this range have produced notable squeezes historically.
  • >30% — extreme; borrow is likely expensive and squeeze risk is material.
  • Days to Cover > 5 combined with high SI% amplifies squeeze potential.
History chart
  • Trend matters more than level. Rapidly rising short interest often precedes negative catalysts or heavy hedging.
  • A sudden drop in SI after a rally may indicate a squeeze in progress.

Short interest is reported mid-month and end-of-month; short volume is daily.

Short Interest
6.12M
SI % of Float
20.68%
Days to Cover
1.00
Short Vol Ratio
63.3%
Free Float
29.62M
Float %
95.9%
Short interest 2026-08-31 • Short volume 2026-09-04 • Float 2026-05-20